Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Top Cited Papers
Open Access
Abstract
There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The transformation of cannabinoids from herbal preparations into highly regulated prescription drugs is therefore progressing rapidly. The development of such drugs requires well-controlled clinical trials to be carried out in order to objectively establish therapeutic efficacy, dose ranges and safety. The low oral bioavailability of cannabinoids has led to feasible methods of administration, such as the transdermal route, intranasal administration and transmucosal adsorption, being proposed. The highly lipophilic nature of cannabinoids means that they are seen as suitable candidates for advanced nanosized drug delivery systems, which can be applied via a range of routes. Nanotechnology-based drug delivery strategies have flourished in several therapeutic fields in recent years and numerous drugs have reached the market. This review explores the most recent developments, from preclinical to advanced clinical trials, in the cannabinoid delivery field, and focuses particularly on pain and inflammation treatment. Likely future directions are also considered and reported.Keywords
This publication has 114 references indexed in Scilit:
- Amygdala activity contributes to the dissociative effect of cannabis on pain perceptionPain, 2013
- CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpuraHaematologica, 2011
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effectsInternational Journal of Interferon, Cytokine and Mediator Research, 2011
- Polymers for Drug Delivery SystemsAnnual Review of Chemical and Biomolecular Engineering, 2010
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related PainJournal of Pain and Symptom Management, 2010
- Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short reviewPharmacology Biochemistry and Behavior, 2008
- Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritisArthritis Research & Therapy, 2008
- Human Cannabinoid PharmacokineticsChemistry & Biodiversity, 2007
- Chemical constituents of marijuana: The complex mixture of natural cannabinoidsLife Sciences, 2005